ACUTE-PHASE EFFICACY IN A PHASE 3 MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ZS-9 FOR HYPERKALAEMIA

被引：0
|
作者：
El-Shahawy, Mohamed A. [1 ]
Rasmussen, Henrik S. [2 ]
Lavin, Philip T. [3 ]
Yang, Alex [4 ]
Packham, David K. [5 ]
机构：
[1] Acad Med Res Inst, Los Angeles, CA USA
[2] ZS Pharma Inc, Coppell, TX USA
[3] Boston Biostat Res Fdn, Framingham, MA USA
[4] Xelay Acumen Inc, Belmont, CA USA
[5] Melbourne Renal Res Grp, Melbourne, Vic, Australia
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP320
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
    Chitnis, Tanuja
    Banwell, Brenda
    Kappos, Ludwig
    Arnold, Douglas L.
    Guecueyener, Kivilcim
    Deiva, Kumaran
    Skripchenko, Natalia
    Cui, Li-Ying
    Saubadu, Stephane
    Hu, Wenruo
    Benamor, Myriam
    Le-Halpere, Annaig
    Truffinet, Philippe
    Tardieu, Marc
    LANCET NEUROLOGY, 2021, 20 (12): : 1001 - 1011
  • [32] A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia
    Lynch, David R.
    Perlman, Susan L.
    Meier, Thomas
    ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 941 - 947
  • [33] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
    Rovin, Brad H.
    Teng, Y. K. Onno
    Ginzler, Ellen M.
    Arriens, Cristina
    Caster, Dawn J.
    Romero-Diaz, Juanita
    Gibson, Keisha
    Kaplan, Joshua
    Lisk, Laura
    Navarra, Sandra
    Parikh, Samir V.
    Randhawa, Simrat
    Solomons, Neil
    Huizinga, Robert B.
    LANCET, 2021, 397 (10289): : 2070 - 2080
  • [34] Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial
    Lyu, Yee Ran
    Yang, Won-Kyung
    Park, So Jung
    Kim, Seung-Hyeong
    Kang, Wee-Chang
    Jung, In Chul
    Park, Yang Chun
    BMJ OPEN, 2018, 8 (05):
  • [35] The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study
    Garcia, Esther
    Robert, Marta
    Peris, Francesc
    Nakamura, Hiroshi
    Sato, Noriko
    Terazawa, Yoshikatsu
    CNS DRUGS, 2009, 23 (07) : 615 - 625
  • [36] Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
    Yang, Zifeng
    Li, Zhengtu
    Zhan, Yangqing
    Lin, Zhengshi
    Fang, Zhonghao
    Xu, Xiaowei
    Lin, Lin
    Li, Haijun
    Lin, Zejun
    Kang, Changyuan
    Liang, Jingyi
    Liang, Shiwei
    Li, Yongming
    Li, Shaoqiang
    Yang, Xinyun
    Ye, Feng
    Zhong, Nanshan
    LANCET INFECTIOUS DISEASES, 2024, 24 (05): : 535 - 545
  • [37] The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase SchizophreniaA Randomized, Double-Blind, Placebo-Controlled, Multicentre Study
    Esther Garcia
    Marta Robert
    Francesc Peris
    Hiroshi Nakamura
    Noriko Sato
    Yoshikatsu Terazawa
    CNS Drugs, 2009, 23 : 615 - 625
  • [38] Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Once-Daily ZS-9 for Treatment of Hyperkalemia: Achievement and Maintenance of K plus in Subgroup Analysis of Patients with Heart Failure not on RAAS Inhibitors
    Singh, Bhupinder
    Rasmussen, Henrik S.
    Lavin, Philip T.
    Yang, Alex
    Packham, David K.
    CIRCULATION, 2014, 130
  • [39] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
    Wallace, Daniel J.
    Furie, Richard A.
    Tanaka, Yoshiya
    Kalunian, Kenneth C.
    Mosca, Marta
    Petri, Michelle A.
    Doerner, Thomas
    Cardiel, Mario H.
    Bruce, Ian N.
    Gomez, Elisa
    Carmack, Tara
    DeLozier, Amy M.
    Janes, Jonathan M.
    Linnik, Matthew D.
    de Bono, Stephanie
    Silk, Maria E.
    Hoffman, Robert W.
    LANCET, 2018, 392 (10143): : 222 - 231
  • [40] Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
    Kappos, Ludwig
    Hartung, Hans-Peter
    Freedman, Mark S.
    Boyko, Alexey
    Radue, Ernst Wilhelm
    Mikol, Daniel D.
    Lamarine, Marc
    Hyvert, Yann
    Freudensprung, Ulrich
    Plitz, Thomas
    van Beek, Johan
    LANCET NEUROLOGY, 2014, 13 (04): : 353 - 363
12345